alzheimers-facts-and-figures.pdf
www.alz.org/media/documents/alzheimers-facts-and-figures.pdf
Mar 15, 2023
2
2022 Alzheimer's disease facts and figures
alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12638
Mar 15, 2023
2
Prevalence of Falls and Fractures in Alzheimer’s Patients Compared to General Population
www.ncbi.nlm.nih.gov/pmc/articles/PMC7906364/
Mar 15, 2023
2
Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease
jamanetwork.com/journals/jama/fullarticle/2442936
Mar 15, 2023
41
Overview — deep learning for molecules & materials
dmol.pub/index.html
Mar 15, 2023
1
Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
www.ncbi.nlm.nih.gov/pmc/articles/PMC5070416/
Mar 15, 2023
3
Pharmacogenetics of anxiety and depression in Alzheimer's disease | Pharmacogenomics
www.futuremedicine.com/doi/10.2217/pgs-2022-0137
Mar 15, 2023
1
Extend Your Startups Runway: How Venture Debt Works
www.svb.com/startup-insights/venture-debt/what-is-venture-debt
Mar 14, 2023
2
Venture Debt: How It Works | Silicon Valley Bank
www.svb.com/startup-insights/venture-debt/how-does-venture-debt-work
Mar 14, 2023
1
Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT - Scientific Reports
www.nature.com/articles/srep38695
Mar 13, 2023
1
Global Alzheimer’s Disease Market $6.3 Billion by 2029
www.ihealthcareanalyst.com/global-alzheimers-disease-market/
Mar 13, 2023
2
Exciva GmbH
www.exciva.com/bpsd
Mar 13, 2023
2
The Fall of the Market in the Fall of 2008
www.investopedia.com/articles/economics/09/subprime-market-2008.asp
Mar 11, 2023
1
What Is the Deal With Silicon Valley Bank?
www.reddit.com/r/OutOfTheLoop/comments/11n88pd/comment/jbm60a7/
Mar 10, 2023
1
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) - Full Text View - ClinicalTrials.gov
clinicaltrials.gov/ct2/show/NCT04576988
Mar 10, 2023
2
Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy | wizdom.ai - intelligence for everyone.
www.wizdom.ai/publication/10.3390/IJMS24032152/title/expression_of_cd22_in_triple_negative_breast_cancer_a_novel_prognostic_biomarker_and_potential_target_for_car_therapy
Mar 9, 2023
4
Merck’s Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy - Merck.com
www.merck.com/news/mercks-investigational-activin-signaling-inhibitor-sotatercept-improved-six-minute-walk-distance-by-40-8-meters-at-week-24-versus-placebo-in-adults-with-pulmonary-arterial-hypertension-on-bac/
Mar 9, 2023
1
Cowen-Research-Themes-2023.pdf
s33007.pcdn.co/wp-content/uploads/2022/12/Cowen-Research-Themes-2023.pdf
Mar 7, 2023
4
Bi-Specific and Tri-Specific Antibodies- The Next Big Thing in Solid Tumor Therapeutics
molmed.biomedcentral.com/articles/10.1186/s10020-018-0051-4
Mar 1, 2023
2
The Biggest Company in the World | Andreessen Horowitz
a16z.com/2022/11/11/the-biggest-company-in-the-world/
Mar 1, 2023
1
Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
www.frontiersin.org/articles/10.3389/fmed.2020.604961/full
Feb 27, 2023
1
Wikiwand - Complement system
www.wikiwand.com/en/Complement_system
Feb 22, 2023
7
Orphanet: C3 glomerulopathy
www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=329918
Feb 21, 2023
1
Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria
www.ncbi.nlm.nih.gov/pmc/articles/PMC7892643/
Feb 21, 2023
1
complement system factor H diseases | Search | Elicit
elicit.org/search?q=complement+system+factor+H+diseases&token=01GSTNNQGCJ23A7WF393Z9AB1B&paper=cafb5ca588265b6f1fdb1786d2967618fa501702&column=title&s-pr=year
Feb 21, 2023
1
Effect Size
onbiostatistics.blogspot.com/2009/04/effect-size.html
Feb 21, 2023
2
Strengths & Weaknesses
www.16personalities.com/enfj-strengths-and-weaknesses
Feb 14, 2023
2
Megathread/Reading_material_and_elearning - Piracy
www.reddit.com/r/Piracy/wiki/megathread/reading_material_and_elearning/#wiki_.25BA_manga
Feb 14, 2023
1
Melatonin — Health Benefits, Dosage, Safety, Side-Effects, and More | Supplements - Examine
examine.com/supplements/melatonin/#dosage-information
Feb 14, 2023
1
Research Breakdown on Melatonin - Examine
examine.com/supplements/melatonin/research/
Feb 14, 2023
1
(8) Immunology - Innate Immunity (Complement System Overview) - YouTube
www.youtube.com/watch?v=2-57bqFSJ1E
Feb 11, 2023
1
Biologics vs small molecule drugs – what’s the difference?
www.admescope.com/whats-new/blog/2018/biologics-vs-small-molecule-drugs-whats-the-difference.html
Feb 10, 2023
2
Alexion-AstraZeneca-Rare-Disease-Investor-Event_06-SEPT-2022.pdf
www.astrazeneca.com/content/dam/az/Investor_Relations/events/Alexion-AstraZeneca-Rare-Disease-Investor-Event_06-SEPT-2022.pdf
Feb 9, 2023
4
Wikiwand - Opsonin
www.wikiwand.com/en/Opsonin
Feb 7, 2023
2
PitchBook Profile - Synnovation Therapeutics
my.pitchbook.com/profile/484385-41/company/profile
Feb 7, 2023
3
Wikiwand - Sleeping Beauty transposon system
www.wikiwand.com/en/Sleeping_Beauty_transposon_system
Feb 6, 2023
1
Complement inhibition: a promising concept for cancer treatment
www.ncbi.nlm.nih.gov/pmc/articles/PMC3733085/
Feb 6, 2023
1
Science - Immusoft
www.immusoft.com/science/
Feb 6, 2023
3
Papers and Patents Are Becoming Less Disruptive Over Time - Nature
www.nature.com/articles/s41586-022-05543-x
Jan 13, 2023
3
Papers and Patents Are Becoming Less Disruptive Over Time
www.nature.com/articles/s41586-022-05543-x.pdf
Jan 13, 2023
1
(138) Tiago Forte | Building a Second Brain | Talks at Google - YouTube
www.youtube.com/watch?v=Y86GOtc1KNo
Jan 12, 2023
2
TensorFlow 2 Tutorial: Get Started in Deep Learning with tf.keras - MachineLearningMastery.com
machinelearningmastery.com/tensorflow-tutorial-deep-learning-with-tf-keras/
Jan 12, 2023
6
Evaluate the Performance of Deep Learning Models in Keras - MachineLearningMastery.com
machinelearningmastery.com/evaluate-performance-deep-learning-models-keras/
Jan 12, 2023
2
Wikiwand - Cross-validation (statistics)
www.wikiwand.com/en/Cross-validation_(statistics)
Jan 12, 2023
2
Data Blending vs. Custom Geocoding
help.tableau.com/current/pro/desktop/en-us/maps_customgeocode_datablend.htm
Jan 10, 2023
1
How to Choose an Activation Function for Deep Learning - MachineLearningMastery.com
machinelearningmastery.com/choose-an-activation-function-for-deep-learning/
Jan 7, 2023
4
Loss Functions and Their Use In Neural Networks
towardsdatascience.com/loss-functions-and-their-use-in-neural-networks-a470e703f1e9
Jan 7, 2023
7
Highlights ― Raindrop.io Help
help.raindrop.io/highlights/#add-extension
Jan 4, 2023
1
2. Introduction to Machine Learning — deep learning for molecules & materials
dmol.pub/ml/introduction.html
Dec 28, 2022
2
Tanimoto VS. Mol2vec
medium.com/gsi-technology/tanimoto-vs-mol2vec-7fa4af3208ef
Dec 27, 2022
1
Eager Execution vs. Graph Execution: Which is Better?
towardsdatascience.com/eager-execution-vs-graph-execution-which-is-better-38162ea4dbf6
Dec 27, 2022
3